Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Toyota Motor Corporation, BioTech

Available for purchase to provide the joy of walking to more patients

21.11.2019 - 06:53:08

Toyota Refines Rehabilitation Assist Robot and Launches New Welwalk WW-2000

TOKYO, Nov 21, 2019 - (JCN Newswire) - Toyota Motor Corporation (Toyota) has announced the launch of its new Welwalk WW-2000, a robot designed to provide rehabilitation support to individuals with lower limb paralysis as a result of stroke and other causes. Orders for the new model commenced in November 2019 and planned to be delivered in February 2020.




The Welwalk WW-2000 upgrades the various features of the prior model (the Welwalk WW-1000), namely the rehabilitation support functions based on motor learning theory and the ease of use in clinical settings. Specifically, it adds functions that display assistance settings in real time to improve abnormal gait as well as a game function that helps maintain motivation so patients continue their rehabilitation efforts. The adoption of these new functions reduces burdens on therapists compared to the previous model while providing more efficient walking training to patients.

The prior model was provided on a rental basis to medical institution, but in light of requests from healthcare institutions and market assessments, the Welwalk WW-2000 will be made available for purchase with the aim of improving overall quality of service. In addition, production will be implemented at the Motomachi Plant, with a sales target of 50 units sold to medical institutions annually.

In line with the vision of "freedom of mobility for all, and the joy of self-reliance," Toyota has been developing rehabilitation assist robots in collaboration with Fujita Health University in Toyoake City, Aichi Prefecture since the end of 2007, with the robots used in pilot testing in healthcare settings and clinical research at medical institutions starting in 2011. In 2017, rental of the Welwalk WW-1000, which was the first Toyota product to receive approval as a medical device, commenced. The Welwalk WW-1000 received the 8th Robot Award* in 2018, and to date, it has been used at approximately 80 medical institutions in Japan. With the launch of the Welwalk WW-2000, Toyota hopes to bring the "joy of walking with one's own feet" to even more patients while reducing burdens on therapists.

*The 8th Robot AwardWith the aim of growth and broadening the utilization of robotics technologies, it awards the most excellent robots, parts, software and the related utilization, R&D and the activities of human development, through the coordination of Japan Machinery Federation and Ministry of Economy, Trade and Industry.

About Toyota Motor Corporation

Toyota Motor Corporation (TMC) is the global mobility company that introduced the Prius hybrid-electric car in 1997 and the first mass-produced fuel cell sedan, Mirai, in 2014. Headquartered in Toyota City, Japan, Toyota has been making cars since 1937. Today, Toyota proudly employs 370,000 employees in communities around the world. Together, they build around 10 million vehicles per year in 29 countries, from mainstream cars and premium vehicles to mini-vehicles and commercial trucks, and sell them in more than 170 countries under the brands Toyota, Lexus, Daihatsu and Hino. For more information, please visit www.toyota-global.com.

Source: Toyota Motor Corporation

Contact:
Public Affairs Division
Global Communications Department
Toyota Motor Corporation
Tel: +81-3-3817-9926


Copyright 2019 JCN Newswire . All rights reserved.
@ japancorp.net